SCHEMBL7098246

SCHEMBL7098246

Cc1ccc(Cl)cc1-c1ccc(C2C(=O)NC(C)C2=O)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
MAP4K4 O95819 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
IDO1 P14902 1/20 0.34
ABL1 P00519 1/20 0.33
PDK1 Q15118 1/20 0.33
RAB9A P51151 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
GAA P10253 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
ALPG P10696 1/20 0.32
ALOX12 P18054 1/20 0.32
KMT2A Q03164 1/20 0.32
PPOX P50336 1/20 0.31
JAK2 O60674 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6207998 0.83 ALDH1A1 (0.49) ALDH1A1RAB9AMAPTHPGDTSHR
SCHEMBL812402 0.78 PGR (0.49) ALDH1A1MAPTHPGDTSHRPGR
SCHEMBL8557122 0.75 GAA (0.42) ALDH1A1CYP3A4MAPTHPGDTSHR
SCHEMBL13176931 0.71 MAP4K4 (0.50) MAP4K4IDO1ABL1PDK1RAB9A
SCHEMBL8650400 0.70 GAA (0.54) ALDH1A1MAPTHPGDTSHRGAA
SCHEMBL10389844 0.68 MAP4K4 (0.47) ALDH1A1MAP4K4IDO1ABL1PDK1
SCHEMBL16574082 0.66 MAP4K4 (0.50) ALDH1A1MAP4K4IDO1ABL1CYP3A4
SCHEMBL5771881 0.66 MAPT (0.33) ALDH1A1CYP3A4MAPTHPGDNPSR1
SCHEMBL4433341 0.66 GAA (0.40) ALDH1A1RAB9AHPGDGAAMEN1
SCHEMBL18707547 0.65 PTGS2 (0.60) LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030096806-A1 Arylphenyl-substituted cyclic ketoenols LIEB FOLKER (DE) 2003-05-22 US disclosed
US-6451843-B1 Arylphenyl-substituted cyclic keto enols BAYER AKTIENGESELLSCHAFT (DE) 2002-09-17 US disclosed
EP-1075465-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO ENOLS BAYER AG (DE) 2001-02-14 EP disclosed
WO-1999055673-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO ENOLS BAYER AKTIENGESELLSCHAFT (DE) 1999-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096806-A1 Arylphenyl-substituted cyclic ketoenols KCNE1, KCNQ3, SULT1E1 ALDH1A1 1961/4885MAP4K4 1803/4885L3MBTL1 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.